Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3139-3143

  Matsuyama, Hideyasu ^a   Oba, Kazuo ^a   Yoshihiro, Satoru ^a   Matsuda, Kenji ^a   Naito, Katsusuke ^a   Pan, Yi ^b   Hägarth, Lars ^b   Kudren, David ^b   Bergerheim, Ulf S R ^b   Ekman, Peter ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 8P; CHROMOSOME DELETION; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; SWEDEN;

EID: 0034796683     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
2. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
3. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma
4. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization
5. Chromosome 16q24 deletion and decreased E-cadherin expression: Possible association with metastatic potential in prostate cancer
6. Clinical evidence for and implications of the multistep development of prostate cancer
7. A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans
8. Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir
9. TNM classification of malignant tumours
10. Histological typing of prostate tumours
11. Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy
12. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries
13. Characterization of a human chromosome 8 cosmid library constructed from flow-sorted chromosomes
14. Non-random numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer
15. Nonparametric estimation from incomplete observation
16. Regression models and life-tables
17. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy
18. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer
19. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
20. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3
21. Two putative tumor suppressor genes on chromosome 8p may play different roles in prostate cancer
22. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma
23. Prognostic significance of allelic imbalance of chromosome arms 7q, Bp, 16q, and 18q in stage T3NOMO prostate cancer
24. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer
25. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
26. Interphase cytogenetics of prostatic tumor progression: Specific chromosomal abnormalities are involved in metastasis to the bone
27. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line
28. Precise microdissection of human prostate cancers reveals genotypic heterogeneity
29. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer
30. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies